Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of June 12, 2025 • 6:00 AM ET

Date/Time Source News Release
06/05/2025 07:00 AM EDT Newsfile Theralase Annual General Meeting
05/30/2025 07:00 AM EDT Newsfile Theralase(R) 1Q2025 Financial Statements
05/29/2025 04:30 PM EDT Newsfile CORRECTION FROM SOURCE: Theralase to Present Groundbreaking Research at ASTRO 2025
05/28/2025 07:00 AM EDT Newsfile Theralase to Present Groundbreaking Research at ASTRO 2025
05/20/2025 07:00 AM EDT Newsfile Theralase Provides Corporate Update
05/05/2025 07:00 AM EDT Newsfile Theralase Clinical Data Presented at Canadian Bladder Cancer Forum and American Urological Association
04/28/2025 07:00 AM EDT Newsfile Theralase Discovers New Mechanism of Action of Lead Drug
04/14/2025 04:22 PM EDT Newsfile Theralase(R) Closes Non-Brokered Private Placement
04/10/2025 07:00 AM EDT Newsfile Ruvidar More Effective in the Treatment of Herpes than FDA-Approved Treatments
04/07/2025 07:00 AM EDT Newsfile Ruvidar Demonstrates 7 Year Complete Response
Page

Additional News

As of June 12, 2025 • 6:00 AM ET

Date/Time Source News Release
05/29/2025 07:00 AM EDT Canadian Earnings Reports Expected Canadian Company Earnings on Thursday, May 29th, 2025
05/29/2025 05:31 AM EDT Canadian Earnings Reports Expected earnings - Theralase Technologies Inc.
11/29/2024 04:31 AM EST Canadian Earnings Reports Expected earnings - Theralase Technologies Inc.
11/15/2024 07:00 AM EST ACCESSWIRE IA Theralase(R) Closes Non-Brokered Private Placement
11/12/2024 06:23 PM EST ACCESSWIRE IA Theralase(R) Extends Warrants
10/21/2024 04:31 PM EDT QM Canadian Market Movers Canadian Companies Moving the Markets, Evening edition
Mon, Oct 21, 2024 as of 4:00 pm ET
08/21/2024 10:07 AM EDT Baystreet Stocks in Play: Theralase® Technologies Inc.
05/31/2024 05:35 AM EDT Canadian Earnings Reports Expected earnings - Theralase Technologies Inc.
02/08/2024 09:34 AM EST News Direct Theralase Technologies shares update on Phase II Bladder Cancer study
12/04/2023 01:16 PM EST News Direct Theralase makes positive progress on Phase II study on bladder cancer; targets breakthrough designation with FDA
Page

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.